James E Thompson

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Prognostic Factors

Patient Reported Outcomes

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jurjen Versluis, Manu Pandey, Yael Flamand, J Erika Haydu, Roger Belizaire, Mark G Faber, Rahul S Vedula, Anne Charles, Kevin M Copson, Shai Shimony, Alon Rozental, Pavan K Bendapudi, Ofir Wolach, Elizabeth A Griffiths, James E Thompson, Richard M Stone, Daniel J DeAngelo, Donna Neuberg, Marlise R Luskin, Eunice S Wang, R Coleman Lindsley
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy. Blood advances 6 (9) (2022)
Amanda C Przespolewski, Aaron D Goldberg, Chetasi Talati, Salman Fazal, Pankit Vachhani, Srinivasa Reddy Sanikommu, Swapna Thota, Julian A Waksal, Brian John Ball, Christopher A Famulare, Maximilian Stahl, Jeffrey Baron, Elizabeth A Griffiths, James E Thompson, Kendra L Sweet, Eunice S Wang
Safety and efficacy of CPX-351 in younger patients (< 60 years) with secondary acute myeloid leukemia. Blood (2022)
Amanda C Przespolewski, Aaron D Goldberg, Chetasi Talati, Salman Fazal, Pankit Vachhani, Srinivasa Reddy Sanikommu, Swapna Thota, Julian A Waksal, Brian John Ball, Christopher A Famulare, Maximilian Stahl, Jeffrey Baron, Elizabeth A Griffiths, James E Thompson, Kendra L Sweet, Eunice S Wang
Safety and efficacy of CPX-351 in younger patients (< 60 years) with secondary acute myeloid leukemia. Blood (2022)